- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
市场最近连续上涨中，短期小心回调。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有146家主力机构披露2025-06-30报告期持股数据，持仓量总计6946.51万股，占流通A股20.22%
- 波段诊断：
-
技术面诊股
诊断结果：4.2技术面打败了7%的股票
技术面评分前10的股票
近期的平均成本为20.62元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为20.62元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.62","date":1767779555,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2026.01.08","stock":false,"trade":"1.15","ind":"-0.07"},{"date":"2026.01.07","stock":false,"trade":"0.44","ind":"0.05"},{"date":"2026.01.06","stock":false,"trade":"0.51","ind":"1.50"},{"date":"2026.01.05","stock":false,"trade":"3.09","ind":"1.38"},{"date":"2025.12.31","stock":"0.57","trade":"-0.07","ind":"0.09"},{"date":"2025.12.30","stock":"0.06","trade":"-0.48","ind":"-0.00"},{"date":"2025.12.29","stock":"-1.12","trade":"-1.13","ind":"0.04"},{"date":"2025.12.26","stock":"-1.43","trade":"-0.41","ind":"0.10"},{"date":"2025.12.25","stock":"0.11","trade":"0.35","ind":"0.47"},{"date":"2025.12.24","stock":"0.28","trade":"0.28","ind":"0.53"},{"date":"2025.12.23","stock":"-1.47","trade":"-0.30","ind":"0.07"},{"date":"2025.12.22","stock":"-1.61","trade":"0.14","ind":"0.69"},{"date":"2025.12.19","stock":"0.22","trade":"1.80","ind":"0.36"},{"date":"2025.12.18","stock":"2.54","trade":"0.51","ind":"0.16"},{"date":"2025.12.17","stock":"0.06","trade":"0.69","ind":"1.19"},{"date":"2025.12.16","stock":"-1.57","trade":"-2.00","ind":"-1.11"},{"date":"2025.12.15","stock":"-1.50","trade":"-1.10","ind":"-0.55"},{"date":"2025.12.12","stock":"0.27","trade":"-0.50","ind":"0.41"},{"date":"2025.12.11","stock":"-1.17","trade":"-0.87","ind":"-0.70"},{"date":"2025.12.10","stock":"0.53","trade":"-0.07","ind":"-0.23"},{"date":"2025.12.09","stock":"-2.85","trade":"-1.51","ind":"-0.37"}]
汇宇制药,上证指数,化学制药指数
压力支撑
该股压力位为20.19元，支撑位为19.21元。
[{"text":"\u538b\u529b\u4f4d","value":"20.19","date":1767801600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.21","date":1767801600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：8.0资金面打败了98%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：01月08日 20:45
| 机构今日流向(万元) | -481.59 | 机构5日流向(万元) | 2440.00 |
| 机构10日流向(万元) | -2106.43 | 机构20日流向(万元) | -5066.39 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加609.52万股，其中基金净减仓10家，主力净增仓20家，请投资者中长期谨慎为宜。
截止2025-06-30，共146家主力机构（基金142家，一般法人3家，券商集合理财1家），持仓量总计6946.51万股，占流通A股20.22%
其中，基金持仓与2024-12-31相比：
增仓：10家 ，增持 300.87万股
减仓：20家 ，减持 569.85万股
新出现在主力名单中：105家 ，持有2347.73万股
从主力名单中消失：85家 ，原持有1440.99万股
其中，基金持仓与2024-12-31相比：
增仓：10家 ，增持 300.87万股
减仓：20家 ，减持 569.85万股
新出现在主力名单中：105家 ，持有2347.73万股
从主力名单中消失：85家 ，原持有1440.99万股
消息面诊股
诊断结果：5.5消息面打败了92%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 利好不断！这一板块多股拉涨！龙头股开年涨幅近70%
2026-01-08 - 创新药板块表现活跃，必贝特盘中创新高
2026-01-08 - 汇宇制药：1月7日获融资买入3036.59万元
2026-01-08 - 汇宇制药：1月6日获融资买入2852.87万元
2026-01-07 - 汇宇制药：1月5日获融资买入1165.78万元
2026-01-06 - 汇宇制药连续2日融资买入额增长率超50%，多头加速
2026-01-06 - 汇宇制药：12月31日获融资买入649.24万元
2026-01-01 - 汇宇制药：12月30日获融资买入283.24万元
2025-12-31 - 汇宇制药：12月29日获融资买入946.97万元
2025-12-30 - 券商观点|医药生物行业周报：春季行情有望启动，关注
2025-12-29
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-12-20 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-10-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-16 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-08-15 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-06-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-06-10 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 利好 | 分红转增 | 10派4.632元(含税) | 2025-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-25 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-01-23 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-01-21 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：2.9行业面打败了23%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.01.08","price":"-0.07","value":"-0.48"},{"date":"2026.01.07","price":"0.05","value":"-1.13"},{"date":"2026.01.06","price":"1.50","value":"-0.41"},{"date":"2026.01.05","price":"1.38","value":"0.35"},{"date":"2025.12.31","price":"0.09","value":"0.28"},{"date":"2025.12.30","price":"-0.00","value":"-0.30"},{"date":"2025.12.29","price":"0.04","value":"0.14"},{"date":"2025.12.26","price":"0.10","value":"1.80"},{"date":"2025.12.25","price":"0.47","value":"0.51"},{"date":"2025.12.24","price":"0.53","value":"0.69"},{"date":"2025.12.23","price":"0.07","value":"-2.00"},{"date":"2025.12.22","price":"0.69","value":"-1.10"},{"date":"2025.12.19","price":"0.36","value":"-0.50"},{"date":"2025.12.18","price":"0.16","value":"-0.87"},{"date":"2025.12.17","price":"1.19","value":"-0.07"},{"date":"2025.12.16","price":"-1.11","value":"-1.51"},{"date":"2025.12.15","price":"-0.55","value":"0.25"},{"date":"2025.12.12","price":"0.41","value":"0.10"},{"date":"2025.12.11","price":"-0.70","value":"-0.40"},{"date":"2025.12.10","price":"-0.23","value":"-0.45"},{"date":"2025.12.09","price":"-0.37","value":"-1.08"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 宏源药业 | 27.83% | -9.06% | 5.3分 |
| 2 | 新诺威 | 26.89% | 11.79% | 5.6分 |
| 3 | 亚虹医药 | 17.69% | 4.54% | 5.9分 |
| 4 | 花园生物 | 15.69% | 8.43% | 6.1分 |
| 5 | 苑东生物 | 14.79% | 6.21% | 6.3分 |
| 6 | 北陆药业 | 13.92% | 15.77% | 6.7分 |
| 8 | 奥锐特 | 11.19% | 4.90% | 6.6分 |
| 10 | 力生制药 | 10.21% | 1.78% | 5.5分 |
| 12 | 莱美药业 | 9.84% | 2.29% | 5.5分 |
| 14 | 微芯生物 | 8.54% | 1.74% | 5.9分 |
| 16 | 多瑞医药 | 7.07% | -3.22% | 6.2分 |
| 18 | 金陵药业 | 6.91% | 2.79% | 6.0分 |
| 20 | 联环药业 | 6.49% | 4.12% | 5.4分 |
| 22 | 康芝药业 | 6.11% | -4.10% | 4.8分 |
| 24 | 广济药业 | 4.82% | 18.31% | 6.0分 |
| 26 | 科源制药 | 4.38% | -2.34% | 4.4分 |
| 28 | 海创药业 | 4.06% | -4.25% | 4.5分 |
| 30 | 海辰药业 | 3.63% | 4.00% | 5.3分 |
| 32 | 翰宇药业 | 3.16% | 7.45% | 6.3分 |
| 34 | 兴齐眼药 | 3.06% | 9.06% | 6.7分 |
| 36 | 奥翔药业 | 2.87% | 4.16% | 5.6分 |
| 38 | 国药现代 | 2.55% | 3.36% | 6.1分 |
| 40 | 贝达药业 | 2.41% | 5.85% | 6.0分 |
| 42 | 易明医药 | 2.11% | 1.77% | 5.2分 |
| 44 | 丽珠集团 | 1.83% | 4.98% | 6.1分 |
| 46 | 上海谊众 | 1.60% | 0.45% | 6.1分 |
| 48 | 华特达因 | 1.52% | 1.03% | 5.2分 |
| 50 | 国邦医药 | 1.27% | 6.57% | 6.5分 |
| 52 | 美诺华 | 1.05% | 3.10% | 5.6分 |
| 54 | 益方生物 | 0.93% | -8.90% | 4.6分 |
| 56 | 恒瑞医药 | 0.82% | 5.68% | 6.5分 |
| 58 | 小方制药 | 0.76% | 1.42% | 5.5分 |
| 60 | 新天地 | 0.66% | 4.19% | 5.4分 |
| 62 | 誉衡药业 | 0.00% | 3.58% | 5.9分 |
| 64 | - | -0.04% | -2.01% | 分 |
| 66 | 福安药业 | -0.22% | 0.90% | 4.2分 |
| 68 | 华润双鹤 | -0.43% | 1.03% | 5.5分 |
| 70 | *ST赛隆 | -0.56% | 3.60% | 4.9分 |
| 72 | 华纳药厂 | -0.62% | -2.85% | 5.8分 |
| 74 | 本立科技 | -0.73% | 2.38% | 5.4分 |
| 76 | 辰欣药业 | -0.87% | 1.79% | 5.4分 |
| 78 | 司太立 | -1.12% | 2.64% | 6.1分 |
| 80 | ST人福 | -1.30% | -0.11% | 4.7分 |
| 82 | 威尔药业 | -1.60% | 0.49% | 5.7分 |
| 84 | 双鹭药业 | -1.64% | 4.99% | 5.5分 |
| 86 | 东北制药 | -1.65% | 2.10% | 5.6分 |
| 88 | 亚太药业 | -2.03% | 5.46% | 6.2分 |
| 90 | 广生堂 | -2.27% | 0.01% | 4.7分 |
| 92 | 百济神州 | -2.40% | -3.35% | 5.4分 |
| 94 | 海欣股份 | -2.44% | 2.85% | 4.5分 |
| 96 | *ST景峰 | -2.72% | 3.16% | 5.0分 |
| 98 | ST天圣 | -2.98% | 1.24% | 4.7分 |
| 100 | 赛托生物 | -3.01% | 4.72% | 4.9分 |
| 102 | - | -3.39% | -1.85% | 分 |
| 104 | 哈药股份 | -3.57% | 0.57% | 4.9分 |
| 106 | *ST三圣 | -3.66% | -1.32% | 4.4分 |
| 108 | 西点药业 | -3.93% | 3.83% | 5.4分 |
| 110 | - | -4.00% | -1.97% | 分 |
| 112 | 仙琚制药 | -4.19% | 1.44% | 5.5分 |
| 114 | 同和药业 | -4.23% | 2.67% | 4.5分 |
| 116 | 海南海药 | -4.48% | 5.36% | 5.0分 |
| 118 | 汉商集团 | -4.85% | -1.49% | 5.3分 |
| 120 | 金石亚药 | -5.15% | 3.49% | 4.6分 |
| 122 | - | -5.45% | -3.34% | 分 |
| 124 | 迪哲医药 | -5.53% | -4.00% | 5.1分 |
| 126 | 健康元 | -5.91% | 1.99% | 5.3分 |
| 128 | - | -6.07% | -3.57% | 分 |
| 130 | 神奇制药 | -6.32% | 2.98% | 5.3分 |
| 132 | 华东医药 | -6.44% | -0.03% | 4.6分 |
| 134 | 汇宇制药 | -6.91% | -1.82% | 5.4分 |
| 136 | ST复华 | -7.04% | 2.08% | 4.8分 |
| 138 | - | -7.10% | -3.03% | 分 |
| 140 | 卫信康 | -7.80% | -3.49% | 5.2分 |
| 142 | 哈三联 | -8.69% | 1.73% | 4.4分 |
| 144 | 赛分科技 | -9.08% | -1.99% | 4.9分 |
| 146 | 悦康药业 | -9.56% | -4.64% | 5.6分 |
| 148 | 海思科 | -10.23% | 8.65% | 5.7分 |
| 150 | 必贝特 | -10.39% | -1.66% | 5.3分 |
| 152 | 百利天恒 | -10.67% | -5.53% | 4.8分 |
| 154 | 信立泰 | -13.08% | 2.55% | 5.5分 |
| 156 | 南新制药 | -14.39% | -0.50% | 4.8分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 113/217 ， 18/217。
[{"date":"2025-09-30","value":"-1.32","vol":"1.51"},{"date":"2025-06-30","value":"-2.10","vol":"1.23"},{"date":"2025-03-31","value":"-0.65","vol":"-0.14"},{"date":"2024-12-31","value":"8.40","vol":"19.62"},{"date":"2024-09-30","value":"5.94","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-1.32 | -2.10 | -0.65 | 8.40 | 5.94 |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"80.49","vol":"49.36"},{"date":"2025-06-30","value":"79.40","vol":"49.33"},{"date":"2025-03-31","value":"83.62","vol":"49.14"},{"date":"2024-12-31","value":"83.41","vol":"50.78"},{"date":"2024-09-30","value":"83.15","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
80.49 | 79.40 | 83.62 | 83.41 | 83.15 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 116/217 ， 133/217。
[{"date":"2025-09-30","value":"-12.92","vol":"142.98"},{"date":"2025-06-30","value":"-14.86","vol":"79.25"},{"date":"2025-03-31","value":"-1.46","vol":"-0.67"},{"date":"2024-12-31","value":"18.05","vol":"18.07"},{"date":"2024-09-30","value":"29.24","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-12.92 | -14.86 | -1.46 | 18.05 | 29.24 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-122.35","vol":"-3.26"},{"date":"2025-06-30","value":"-223.78","vol":"58.57"},{"date":"2025-03-31","value":"-155.19","vol":"-11.22"},{"date":"2024-12-31","value":"132.78","vol":"-22.02"},{"date":"2024-09-30","value":"155.62","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-122.35 | -223.78 | -155.19 | 132.78 | 155.62 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 132/217 ， 126/217。
[{"date":"2025-09-30","value":"0.15","vol":"0.31"},{"date":"2025-06-30","value":"0.09","vol":"0.21"},{"date":"2025-03-31","value":"0.05","vol":"0.10"},{"date":"2024-12-31","value":"0.22","vol":"0.43"},{"date":"2024-09-30","value":"0.17","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.09 | 0.05 | 0.22 | 0.17 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.73","vol":"1.94"},{"date":"2025-06-30","value":"0.49","vol":"1.30"},{"date":"2025-03-31","value":"0.22","vol":"0.66"},{"date":"2024-12-31","value":"1.16","vol":"3.19"},{"date":"2024-09-30","value":"0.90","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.73 | 0.49 | 0.22 | 1.16 | 0.90 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"20.18","vol":"4.43"},{"date":"2025-06-30","value":"-13.84","vol":"2.74"},{"date":"2025-03-31","value":"1.07","vol":"-26.98"},{"date":"2024-12-31","value":"33.28","vol":"-373.99"},{"date":"2024-09-30","value":"38.10","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 20.18 | -13.84 | 1.07 | 33.28 | 38.10 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.10","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.59","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.10 | - | 1.59 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/217 ， 100/217。
[{"date":"2025-09-30","value":"2.85","vol":"3.50"},{"date":"2025-06-30","value":"2.86","vol":"3.69"},{"date":"2025-03-31","value":"3.41","vol":"3.61"},{"date":"2024-12-31","value":"2.94","vol":"3.36"},{"date":"2024-09-30","value":"2.71","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.85 | 2.86 | 3.41 | 2.94 | 2.71 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.50","vol":"2.75"},{"date":"2025-06-30","value":"2.51","vol":"2.90"},{"date":"2025-03-31","value":"3.05","vol":"2.83"},{"date":"2024-12-31","value":"2.71","vol":"2.65"},{"date":"2024-09-30","value":"2.47","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.50 | 2.51 | 3.05 | 2.71 | 2.47 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 89/217 ， 92/217。
[{"date":"2025-09-30","value":"23.69","vol":"33.63"},{"date":"2025-06-30","value":"23.65","vol":"33.66"},{"date":"2025-03-31","value":"20.27","vol":"33.90"},{"date":"2024-12-31","value":"23.08","vol":"34.07"},{"date":"2024-09-30","value":"23.21","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.69 | 23.65 | 20.27 | 23.08 | 23.21 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.31","vol":"0.94"},{"date":"2025-06-30","value":"0.31","vol":"0.88"},{"date":"2025-03-31","value":"0.25","vol":"1.47"},{"date":"2024-12-31","value":"0.30","vol":"0.84"},{"date":"2024-09-30","value":"0.30","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.31 | 0.31 | 0.25 | 0.30 | 0.30 |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"4.46","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.49","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.56","blueLineValue":"0.13","type":"YC"}]